Mega Lifesciences introduces Ginsomin Eve for women

pharmacy

In fulfilment of its commitment to total wellness, Mega Lifesciences has officially launched Ginsomin Eve, a comprehensive women’s health formula, into the Nigerian pharmaceutical market.

While presenting the product to pharmacists during the just concluded 88th annual conference of the Pharmaceutical Society of Nigeria (PSN), held at the International Conference Centre, Abuja on 9-13 November, 2015, Pharm. Ifeanyi Offor, Mega Lifesciences senior product manager, explained that the newly unveiled formula would help to support areas of health that are of most interest to women.

“You will agree with me that we can never have a healthy society without healthy women. Therefore I make bold to say that taking care of women’s health is key in building a healthy society.

“For many years now, Mega Lifesciences has been researching into how to put together a unique formulation that can support and sustain women’s health. The result of such intensive research is what we are presenting today – Ginsomin Eve,” he said.

Describing the formula as unprecedented, the senior product manager declared light-heartedly that the company would not stop its sustained enlightenment campaign until every Nigerian woman sees the need to be on a daily dose of the nutrients-based formula.

While quoting Hilary Clinton, United States presidential aspirant, who said that “investing in women is not only the right thing to do, but also the smart thing to do,” Offor noted that Ginsomin Eve is uniquely blended with 11 essential vitamins, 13 minerals and six health-giving phyto-extracts.

While interacting with pharmacists at the conference, the brand expert further disclosed that the crisis of womanhood actually starts in mid life.

“Many things affect the health of women. From the wear-and-tear of childbirth, pressure of work or from the home front, hormonal changes at mid-age, after effects of family planning pills, domestic violence to malnutrition, the list is endless,” he stated.

With the aid of illustrations and diagrams, the pharmacist summarily highlighted the fact that the primary cause of peri-menopausal crisis in the feminine gender is irregular ovulation and adrenal exhaustion.

According to him, when no egg ripens in the ovaries, there is no empty follicle that will turn into corpus luteum to secrete progesterone.

He gave an insight into why, at age 35 (mid age), some women begin to experience decline in hormonal level, low energy, dwindling libido, fatigue, weight gain in the abdominal and buttocks regions, mood swing and irregular ovulation.

Offor equally opined that it is evident that from menopausal to post-menopausal stage (from age of 50), an average woman may experience menses and ovarian function cease, drastic decline in estrogen level, hot flashes, osteoporosis, increase blood cholesterol and carry-over of pre-menopausal symptoms.

“This is where Ginsomin Eve makes the difference. Aside being rich in antioxidants, it comes in variants such as Ginseng, Evening Primrose (oenothera biennis), Collagen Hydrolysate, Aloe Vera, HORSETAIL extract (equisetum avense) and Grape Seed Extract,” he stressed.

When asked about the product’s side effect, the pharmacist intoned that Ginsomin Eve is generally considered safe at the recommended dose. He added that where side effect occurs, they are relatively mild.

The product manager however cautioned surgical patients requiring anaesthesia against taking the Evening Primrose Oil variant two weeks before surgery.

He also added that people with heart or kidney disorders and diabetes should not be allowed to take the product.

In attendance at the product presentation were Pharm. Olumide Akintayo, PSN president; Pharm. Ifeanyi Atueyi, managing director of Pharmanews Limited; Pharm. Lere Baale, director of Business School Netherlands; Pharm. Michael Osakwe, Mega Lifesciences product manager; Pharm N.A.E Mohammed, registrar, Pharmacists Council of Nigeria (PCN); S.S.N Raju, Mega Lifesciences business head (Wellness); Singh Amit, business head (chronic care) and Stephen Habila, medical representative Abuja branch.

Others were Emeka George, MaxCare representative; Sanni Kolawole, senior regional manager; Pharm. Bruno Nwankwo, past chairman, Pharmacists Council of Nigeria (PCN); Mazi Sam Ohuabunwa, former Neimeth Pharmaceuticals Plc CEO; Uche Egbuka, senior medical representatives and Pharm. Ade Popoola, chairman, PSN Board of Fellows.

Mega Lifesciences is a research based multi-national pharmaceutical company with ground presence of business activities in about 35 countries across the globe.

A leading manufacturer of soft gel capsules, with state-of-the-art manufacturing plants in Thailand and Australia, its key brands include Livolin Forte, the three-in-one liver protector; Ginsomin, a premium multivitamin for everyday good health; and Panfor-SR, the sustained release Metformin.